Press Room
JDRF Partner ViaCyte to Immediately Initiate Type 1 Diabetes Clinical Trial
JDRF’s partner ViaCyte recently announced the U.S. Food and Drug Administration (FDA) is allowing them to move forward with a clinical...
Read MoreJDRF Partner ViaCyte Announces Key Project Milestone
JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes
Novo Nordisk Commits $5 Million Grant Supporting JDRF Outreach Initiative
To address the need for education on how patients with type 1 diabetes (T1D) can pursue physical activity safely, Novo Nordisk has committed to a three-year, $5 million grant in support of a new JDRF Outreach initiative titled “T1D Performance in Exercise and Know...
JDRF and the Innovative Medicines Initiative Partner for Type 1 Diabetes Research
JDRF and the Innovative Medicines Initiative (IMI) have partnered on a new precompetitive type 1 diabetes research consortium entitled “TRANSLATIONAL APPROACHES TO DISEASE MODIFYING THERAPY OF TYPE 1 DIABETES MELLITUS (T1DM)”.
Canadians Lace-up And Walk In The 2014 Telus Walk To Cure Diabetes
On June 8, Canadians in approximately 70 cities across the nation will “Join the Community” as they take part in the 2014 TELUS Walk to Cure Diabetes and walk toward a cure for type 1 diabetes (T1D).
JDRF Supporters Gear Up for the Barrie Waterfront Half Marathon
On Saturday, June 21, 2014, the fourth annual Barrie Waterfront Half Marathon, 10K & 5K is taking place throughout the streets of Barrie and along scenic Lake Simcoe. JDRF is once again honoured to be one of the six featured charities in this year&rsq...
JDRF Applauds the Government of British Columbia for extending coverage of the insulin pump program to British Columbians living with type 1 diabetes
JDRF applauds the Government of British Columbia for extending coverage of the insulin pump program for eligible British Columbians aged 19 to 25 years old. Currently, British Columbia covers the costs of insulin pumps to anyone 18 years and younger who are living with type 1 diabetes (T1D...
Canada at the Forefront of Diabetes Research, Bringing Innovation from the Lab to the Bedside
JDRF Canadian Clinical Trial Network (JDRF CCTN) has announced the official launch of its expansion to western Canada through the generous support of the WB Family Foundation.
JDRF to Provide Additional Support for Upcoming Clinical Trial of ViaCyte's Encapsulated Cell Therapy for Type 1 Diabetes
JDRF, the world’s largest non-profit supporter of type 1 diabetes (T1D) research, and ViaCyte, Inc., a leading regenerative medicine company, jointly announced that JDRF is providing additional milestone-based funding for the continued development of ViaCyte’s VC-01™...
Six-Time Ironman and Type 1 Diabetes Athlete Sebastien Sasseville to Take on Solo 7500 km Run Across Canada
Endurance athlete, six-time Ironman and one of more than 3 million Canadians living with diabetes, Sebastien Sasseville will undertake a solo run across the country in a personal mission to inspire, educate and empower other people with diabetes to pursue their dreams.
.png)
